BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND uPA AND Treatment
32 results:

  • 1. Impaired fibrinolysis and increased clot strength are potential risk factors for thrombosis in lymphoma.
    Bønløkke ST; Fenger-Eriksen C; Ommen HB; Hvas AM
    Blood Adv; 2023 Nov; 7(22):7056-7066. PubMed ID: 37756519
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Amentoflavone Induces Apoptosis and Reduces Expression of Anti-apoptotic and Metastasis-associated Proteins in Bladder Cancer.
    Chiang CH; Yeh CY; Chung JG; Chiang IT; Hsu FT
    Anticancer Res; 2019 Jul; 39(7):3641-3649. PubMed ID: 31262890
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Characteristics of fibrinolytic disorders in acute promyelocytic leukemia.
    Wang P; Zhang Y; Yang H; Hou W; Jin B; Hou J; Li H; Zhao H; Zhou J
    Hematology; 2018 Dec; 23(10):756-764. PubMed ID: 29724147
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Targeted abrogation of diverse signal transduction cascades by emodin for the treatment of inflammatory disorders and cancer.
    Shrimali D; Shanmugam MK; Kumar AP; Zhang J; Tan BK; Ahn KS; Sethi G
    Cancer Lett; 2013 Dec; 341(2):139-49. PubMed ID: 23962559
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Autocrine human growth hormone increases sensitivity of mammary carcinoma cell to arsenic trioxide-induced apoptosis.
    Zekri A; Ghaffari SH; Yousefi M; Ghanizadeh-Vesali S; Mojarrad M; Alimoghaddam K; Ghavamzadeh A
    Mol Cell Endocrinol; 2013 Sep; 377(1-2):84-92. PubMed ID: 23851143
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Development of novel therapeutics targeting the urokinase plasminogen activator receptor (upaR) and their translation toward the clinic.
    Mazar AP; Ahn RW; O'Halloran TV
    Curr Pharm Des; 2011; 17(19):1970-8. PubMed ID: 21711234
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Rapid mobilization of hematopoietic progenitors by AMD3100 and catecholamines is mediated by CXCR4-dependent SDF-1 release from bone marrow stromal cells.
    Dar A; Schajnovitz A; Lapid K; Kalinkovich A; Itkin T; Ludin A; Kao WM; Battista M; Tesio M; Kollet O; Cohen NN; Margalit R; Buss EC; Baleux F; Oishi S; Fujii N; Larochelle A; Dunbar CE; Broxmeyer HE; Frenette PS; Lapidot T
    Leukemia; 2011 Aug; 25(8):1286-1296. PubMed ID: 21494253
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Clinical and molecular features of papillary thyroid cancer in adolescents and young adults.
    Vriens MR; Moses W; Weng J; Peng M; Griffin A; Bleyer A; Pollock BH; Indelicato DJ; Hwang J; Kebebew E
    Cancer; 2011 Jan; 117(2):259-67. PubMed ID: 20824721
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. NF-kappaB inhibition in human hepatocellular carcinoma and its potential as adjunct to sorafenib based therapy.
    Wu JM; Sheng H; Saxena R; Skill NJ; Bhat-Nakshatri P; Yu M; Nakshatri H; Maluccio MA
    Cancer Lett; 2009 Jun; 278(2):145-155. PubMed ID: 19303700
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Identification of candidate predictive and surrogate molecular markers for dasatinib in prostate cancer: rationale for patient selection and efficacy monitoring.
    Wang XD; Reeves K; Luo FR; Xu LA; Lee F; Clark E; Huang F
    Genome Biol; 2007; 8(11):R255. PubMed ID: 18047674
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The gp130 ligand oncostatin M regulates tissue inhibitor of metalloproteinases-1 through ERK1/2 and p38 in human adult cardiac myocytes and in human adult cardiac fibroblasts: a possible role for the gp130/gp130 ligand system in the modulation of extracellular matrix degradation in the human heart.
    Weiss TW; Kvakan H; Kaun C; Zorn G; Speidl WS; Pfaffenberger S; Maurer G; Huber K; Wojta J
    J Mol Cell Cardiol; 2005 Sep; 39(3):545-51. PubMed ID: 15890357
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. An in vitro study on the mechanisms of coagulation activation in acute myelogenous leukemia (AML): role of tissue factor regulation by cytotoxic drugs and GM-CSF.
    Langer F; Amirkhosravi A; Loges S; Meyer T; Eifrig B; Hossfeld DK; Fiedler W; Francis JL
    Thromb Haemost; 2004 Nov; 92(5):1136-46. PubMed ID: 15543344
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Effects of all-trans retinoic acid or chemotherapy on the molecular regulation of systemic blood coagulation and fibrinolysis in patients with acute promyelocytic leukemia.
    Tallman MS; Lefèbvre P; Baine RM; Shoji M; Cohen I; Green D; Kwaan HC; Paietta E; Rickles FR
    J Thromb Haemost; 2004 Aug; 2(8):1341-50. PubMed ID: 15304040
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. A urokinase-activated recombinant diphtheria toxin targeting the granulocyte-macrophage colony-stimulating factor receptor is selectively cytotoxic to human acute myeloid leukemia blasts.
    Abi-Habib RJ; Liu S; Bugge TH; Leppla SH; Frankel AE
    Blood; 2004 Oct; 104(7):2143-8. PubMed ID: 15161668
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Urokinase plasminogen activator receptor and soluble matrix metalloproteinase-9 in acute myeloid leukemia patients: a possible relation to disease invasion.
    Aref S; El-Sherbiny M; Mabed M; Menessy A; El-Refaei M
    Hematology; 2003 Dec; 8(6):385-91. PubMed ID: 14668033
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. SRC family kinases: potential targets for the treatment of human cancer and leukemia.
    Warmuth M; Damoiseaux R; Liu Y; Fabbro D; Gray N
    Curr Pharm Des; 2003; 9(25):2043-59. PubMed ID: 14529415
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The diphtheria toxin/urokinase fusion protein (DTAT) is selectively toxic to CD87 expressing leukemic cells.
    Ramage JG; Vallera DA; Black JH; Aplan PD; Kees UR; Frankel AE
    Leuk Res; 2003 Jan; 27(1):79-84. PubMed ID: 12479856
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. [Clinical significance of hemostatic molecular markers in acute leukemia].
    Wu F; Wang X; Qu B; Huang X; Wang H
    Zhonghua Xue Ye Xue Za Zhi; 2001 Mar; 22(3):141-4. PubMed ID: 11877066
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Matrix and serine protease expression during leukemic cell differentiation induced by aclacinomycin and all-trans-retinoic acid.
    Devy L; Hollender P; Munaut C; Colige A; Garnotel R; Foidart JM; Noël A; Jeannesson P
    Biochem Pharmacol; 2002 Jan; 63(2):179-89. PubMed ID: 11841792
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [A study of tissue factor expression and hemostatic molecular markers in patients with acute promyelocytic leukemia].
    Wu F; Wang X; Zhao W; Wang H; Shen Z
    Zhonghua Nei Ke Za Zhi; 2001 Jan; 40(1):36-9. PubMed ID: 11798557
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.